| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 5 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 18 |
| NetGPI | no | yes: 0, no: 18 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 11 |
| GO:0110165 | cellular anatomical entity | 1 | 12 |
| GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: E9AKF5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 51 | 55 | PF00656 | 0.609 |
| CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.399 |
| CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.399 |
| CLV_PCSK_KEX2_1 | 31 | 33 | PF00082 | 0.345 |
| CLV_PCSK_PC1ET2_1 | 31 | 33 | PF00082 | 0.346 |
| CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.359 |
| CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.352 |
| CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.286 |
| CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.278 |
| CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.315 |
| DOC_ANK_TNKS_1 | 49 | 56 | PF00023 | 0.608 |
| DOC_CYCLIN_yCln2_LP_2 | 8 | 14 | PF00134 | 0.580 |
| DOC_MAPK_MEF2A_6 | 10 | 18 | PF00069 | 0.630 |
| DOC_MAPK_MEF2A_6 | 40 | 48 | PF00069 | 0.513 |
| DOC_PP4_FxxP_1 | 12 | 15 | PF00568 | 0.633 |
| DOC_WW_Pin1_4 | 119 | 124 | PF00397 | 0.598 |
| DOC_WW_Pin1_4 | 161 | 166 | PF00397 | 0.560 |
| LIG_14-3-3_CanoR_1 | 111 | 115 | PF00244 | 0.613 |
| LIG_14-3-3_CanoR_1 | 148 | 156 | PF00244 | 0.492 |
| LIG_Actin_WH2_2 | 122 | 140 | PF00022 | 0.513 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.657 |
| LIG_EH1_1 | 102 | 110 | PF00400 | 0.400 |
| LIG_FHA_1 | 11 | 17 | PF00498 | 0.633 |
| LIG_FHA_1 | 18 | 24 | PF00498 | 0.632 |
| LIG_FHA_1 | 43 | 49 | PF00498 | 0.585 |
| LIG_FHA_1 | 95 | 101 | PF00498 | 0.268 |
| LIG_FHA_2 | 83 | 89 | PF00498 | 0.249 |
| LIG_LIR_Nem_3 | 113 | 118 | PF02991 | 0.564 |
| LIG_MYND_1 | 116 | 120 | PF01753 | 0.571 |
| LIG_SH2_SRC | 52 | 55 | PF00017 | 0.601 |
| LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.512 |
| LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.330 |
| LIG_SH3_3 | 117 | 123 | PF00018 | 0.607 |
| LIG_SUMO_SIM_par_1 | 13 | 20 | PF11976 | 0.480 |
| MOD_Cter_Amidation | 109 | 112 | PF01082 | 0.500 |
| MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.370 |
| MOD_GSK3_1 | 110 | 117 | PF00069 | 0.570 |
| MOD_GSK3_1 | 157 | 164 | PF00069 | 0.700 |
| MOD_N-GLC_1 | 148 | 153 | PF02516 | 0.448 |
| MOD_NEK2_2 | 110 | 115 | PF00069 | 0.559 |
| MOD_PKA_2 | 110 | 116 | PF00069 | 0.562 |
| MOD_Plk_1 | 42 | 48 | PF00069 | 0.508 |
| MOD_Plk_1 | 82 | 88 | PF00069 | 0.424 |
| MOD_ProDKin_1 | 119 | 125 | PF00069 | 0.593 |
| MOD_ProDKin_1 | 161 | 167 | PF00069 | 0.567 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HTD3 | Leptomonas seymouri | 73% | 100% |
| A0A0S4JQI6 | Bodo saltans | 29% | 100% |
| A0A1X0NJU2 | Trypanosomatidae | 50% | 100% |
| A0A1X0NR99 | Trypanosomatidae | 34% | 100% |
| A0A3S7WP26 | Leishmania donovani | 94% | 100% |
| A0A3S7X736 | Leishmania donovani | 32% | 100% |
| A0A422N2T1 | Trypanosoma rangeli | 54% | 100% |
| A0A422NKR0 | Trypanosoma rangeli | 33% | 100% |
| A4H495 | Leishmania braziliensis | 88% | 100% |
| A4HLZ1 | Leishmania braziliensis | 31% | 100% |
| A4I9C1 | Leishmania infantum | 32% | 100% |
| C9ZJA0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
| C9ZUD9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
| E9B4C0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 33% | 100% |
| Q4Q3Q5 | Leishmania major | 32% | 100% |
| V5BJW3 | Trypanosoma cruzi | 50% | 100% |
| V5DB75 | Trypanosoma cruzi | 32% | 100% |